SBI Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117K Buy
223
+3
+1% +$1.68K ﹤0.01% 853
2026
Q1
$124K Sell
220
-7
-3% -$4.49K ﹤0.01% 785
2025
Q4
$154K Sell
227
-12
-5% -$8.17K ﹤0.01% 706
2025
Q3
$153K Sell
239
-3
-1% -$1.82K ﹤0.01% 712
2025
Q2
$130K Sell
242
-10
-4% -$4.78K ﹤0.01% 728
2025
Q1
$106K Buy
252
+17
+7% +$7.38K ﹤0.01% 725
2024
Q4
$97.2K Buy
+235
New +$103K ﹤0.01% 763

Other funds holding IDXX

SBI Securities's IDXX Position: Q2 2026 in Review

SBI Securities increased its Idexx Laboratories (IDXX) stake by 1.4% in Q2 2026, buying an estimated $1.68K and bringing the position to 223 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #853.

SBI Securities first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $154K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • SBI Securities held 223 shares of Idexx Laboratories worth $117K as of Q2 2026.
  • SBI Securities bought 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
  • Idexx Laboratories made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #853 holding.
  • SBI Securities first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Idexx Laboratories position peaked at $154K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.